Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0000899243-16-031602

Director disposed of 300,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Canaan IX L.P. Director 2016-10-11 Other disposition −300,000 3,944,381 I: show line 1 in the form
Loading xslF345X03/doc4.xml…